AEZSAeterna Zentaris

$-0.06 (-8%)

Aeterna Zentaris (AEZS) Stock Analysis

Create a FREE Account to View Full AEZS Stock Report

Aeterna Zentaris (AEZS) Analyst Forecast

Next 12 months ➝Current Price$0.8052-week High$5.5752-week Low$0.76No Forecast Data Available for AEZS
  • Last Price$0.80
  • Previous Close$0.86
  • Change $-0.06
  • Open$0.80
  • Volume501,149
  • Avg. Volume (100-day)189,396
  • Market Capitalization$18.78M
  • Days Range $0.77 - $0.85
  • 52-week Range $0.76 - $5.57
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS-0.81
  • Earnings Date03/24/2020
  • SectorHealthcare
  • IndustryBiotechnology
  • Avg. Analyst Rec.
  • Beta1.161
  • PEG Ratio
  • Volatility0.86
  • Average True Range0.08
AEterna Zentaris Inc is a specialty biopharmaceutical company. It is involved in development and commercialization of novel pharmaceutical therapies, drug development activities and promotion of products for others in oncology, endocrinology and women's health. The company focuses on the acquisition of licenses to products that are relevant to their therapeutic areas of focus. Its primary product is Apifiny. It is developing Macrilen, Zoptrex and AEZS drugs in the pipeline.